Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down – What’s Next?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX)’s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $15.40, but opened at $14.56. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $14.80, with a volume of 469 shares trading hands.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on TLX. William Blair raised shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th. UBS Group started coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They issued a “buy” rating and a $21.00 target price for the company.

Telix Pharmaceuticals Limited American Depositary Shares Stock Up 3.1 %

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.